- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
Posted on 2/23/23 at 5:45 pm to bayoubengals88
I’m finally riding per today’s extended session
Posted on 2/23/23 at 5:45 pm to bayoubengals88
quote:
Akebia Receives Positive CHMP Opinion in Europe for Vafseo™ (vadadustat) for the Treatment of Symptomatic Anaemia Associated with Chronic Kidney Disease in Adults on Chronic Maintenance Dialysis
LINK
Posted on 2/24/23 at 2:31 pm to bayoubengals88
Wow. Been holding this forever. Trust the process?
Posted on 2/24/23 at 2:34 pm to ShootingsBricks4Life
quote:It's all about the FDA decision. They are running a bit low on cash so I'd look for a public offering after a positive decision.
Wow. Been holding this forever. Trust the process?
If negative, I think this thing is toast.
Their other drug, Auryxia, has generated decent revenue, but it goes off patent in 12 months.
Vafseo is approved in Japan and Europe, but not in the US, yet....
Posted on 2/24/23 at 5:32 pm to bayoubengals88
Mr. Market talking to me about my brand new AKBA shares.
Posted on 2/24/23 at 5:58 pm to LSUcam7
Thank you for reminding me about that character in Vegas Vacation. I had completely forgotten about him.
Posted on 3/9/23 at 7:22 am to LSUcam7
quote:
Thu, March 9, 2023 at 6:30 AM CST
Akebia to host conference call on March 9 at 8:30 a.m. ET
Receives positive CHMP opinion for Vafseo™ (vadadustat); anticipates potential Marketing Authorization in Europe in May 2023
Reports Auryxia® (ferric citrate) net product revenue of $177.1M for 2022, an increase of approximately 24.5% over 2021
Sets 2023 Auryxia net product revenue guidance at $175-$180M
LINK
Posted on 3/9/23 at 9:15 am to bayoubengals88
Any idea if the reverse split is beneficial.
Posted on 3/10/23 at 7:50 am to jerryc436
Should I jump in now at .77?
Posted on 5/17/23 at 4:26 pm to LSUcam7
Anyone still here? Nice little run the past month.
Posted on 5/17/23 at 9:45 pm to Fat Batman
Still here. I have not read any updates to why this increase has occurred though. Would like it to get to $2.
Posted on 5/18/23 at 7:02 am to Fat Batman
quote:
Anyone still here? Nice little run the past month.
I jumped in then at .77. Yay me
Posted on 5/18/23 at 7:24 am to Fat Batman
quote:Still here with 1,050 shares.
Anyone still here? Nice little run the past month.
I'd like to sell covered calls for 2.50 if the opportunity presents itself. If I could get .20 per contract I'd do it.
Posted on 5/22/23 at 10:22 am to Fat Batman
Do we know the timeline for a relook by the FDA?
Posted on 7/17/23 at 12:59 pm to Caymus
Some green today! Anyone still here?
Popular
Back to top
Follow TigerDroppings for LSU Football News